E. Scott Priestley

Also affiliated with Bristol-Myers Squibb (United States)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Development of PVTX-405 as a potent and highly selective molecular glue degrader of IKZF2 for cancer immunotherapy”.

Development of PVTX-405 as a potent and highly selective molecular glue degrader of IKZF2 for cancer immunotherapy

Nature Communications(2025)10.1038/s41467-025-58431-z

N/A

0.464DataRank · unranked

21 citations

Harshil Dhruv, Xuqing Zhang, Rohan Kalyan Rej, Longchuan Bai, Donna McEachern +14 more

Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer

Journal of Medicinal Chemistry(2024)10.1021/acs.jmedchem.4c01521

N/A

0DataRank · unranked

21 citations

Rohan Kalyan Rej, Biao Hu, Zhixiang Chen, Dimin Wu, Jianfeng Lü +18 more

Correction to “Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer”

Journal of Medicinal Chemistry(2025)10.1021/acs.jmedchem.5c00592

N/A

0DataRank · unranked

1 citations

Rohan Kalyan Rej, Biao Hu, Zhixiang Chen, Dimin Wu, Jianfeng Lü +18 more